Flagship Pioneering, LLC
CIK: 0001400240
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Foghorn Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 13, 2026FHTX
Foghorn Therapeutics Inc.
Award(A)IndirectPre-Funded Warrants to purchase Common Stock
2.2M shares at avg. $6.71- - Jan 13, 2026FHTX
Foghorn Therapeutics Inc.
Award(A)IndirectSeries 1 Warrants to purchase Common Stock
1.1M shares- - Jan 13, 2026FHTX
Foghorn Therapeutics Inc.
Award(A)IndirectSeries 2 Warrants to purchase Common Stock
1.1M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 13, 2026 | FHTX Foghorn Therapeutics Inc. | Award(A) Pre-Funded Warrants to purchase Common Stock | 2,235,468 | $6.71 | - | Indirect |
| Jan 13, 2026 | FHTX Foghorn Therapeutics Inc. | Award(A) Series 1 Warrants to purchase Common Stock | 1,117,734 | - | - | Indirect |
| Jan 13, 2026 | FHTX Foghorn Therapeutics Inc. | Award(A) Series 2 Warrants to purchase Common Stock | 1,117,734 | - | - | Indirect |
1-3 of 3 transactions
About Flagship Pioneering, LLC
Flagship Pioneering, LLC (SEC CIK 0001400240) files insider reports with the SEC as Director of Foghorn Therapeutics Inc. (FHTX).
Signal8 holds 1 ownership filing by Flagship Pioneering, LLC, a Form 4, filed on Jan 15, 2026. Those filings report 3 transactions, the latest on Jan 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Flagship Pioneering, LLC's filings is in CAMBRIDGE, MA.
Recent filings by Flagship Pioneering, LLC
- Jan 13, 2026: Grants or awards of FHTX derivative securities (3 lines, Form 4, code A).
Other insiders filing for Foghorn Therapeutics Inc. (FHTX)
- BVF PARTNERS L P/IL, 10% Owner
- Lynch Thomas J. Jr., Director
- Duty Stuart, Director
- Biller Scott, Director
- Gallagher Neil, Director
- Mendelsohn Michael, Director